Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions

The activin–follistatin system regulates several cellular processes, including differentiation and tumorigenesis. We hypothesized that the immunostaining of βA-activin and follistatin varies in neoplastic cervical lesions. Cervical paraffin-embedded tissues from 162 patients sorted in control (<i...

Full description

Bibliographic Details
Main Authors: Victor Jesus Huaringa Payano, Lara Verônica de Araújo Lopes, Larissa Rodrigues Peixoto, Keila Alves da Silva, Tania Maria Ortiga-Carvalho, Alexandre Tafuri, Annamaria Ravara Vago, Enrrico Bloise
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/5/1031
_version_ 1797598115820208128
author Victor Jesus Huaringa Payano
Lara Verônica de Araújo Lopes
Larissa Rodrigues Peixoto
Keila Alves da Silva
Tania Maria Ortiga-Carvalho
Alexandre Tafuri
Annamaria Ravara Vago
Enrrico Bloise
author_facet Victor Jesus Huaringa Payano
Lara Verônica de Araújo Lopes
Larissa Rodrigues Peixoto
Keila Alves da Silva
Tania Maria Ortiga-Carvalho
Alexandre Tafuri
Annamaria Ravara Vago
Enrrico Bloise
author_sort Victor Jesus Huaringa Payano
collection DOAJ
description The activin–follistatin system regulates several cellular processes, including differentiation and tumorigenesis. We hypothesized that the immunostaining of βA-activin and follistatin varies in neoplastic cervical lesions. Cervical paraffin-embedded tissues from 162 patients sorted in control (<i>n</i> = 15), cervical intraepithelial neoplasia (CIN) grade 1 (<i>n</i> = 38), CIN2 (<i>n</i> = 37), CIN3 (<i>n</i> = 39), and squamous cell carcinoma (SCC; <i>n</i> = 33) groups were examined for βA-activin and follistatin immunostaining. Human papillomavirus (HPV) detection and genotyping were performed by PCR and immunohistochemistry. Sixteen samples were inconclusive for HPV detection. In total, 93% of the specimens exhibited HPV positivity, which increased with patient age. The most detected high-risk (HR)-HPV type was HPV16 (41.2%) followed by HPV18 (16%). The immunostaining of cytoplasmatic βA-activin and follistatin was higher than nuclear immunostaining in all cervical epithelium layers of the CIN1, CIN2, CIN3, and SCC groups. A significant decrease (<i>p</i> < 0.05) in the cytoplasmic and nuclear immunostaining of βA-activin was detected in all cervical epithelial layers from the control to the CIN1, CIN2, CIN3, and SCC groups. Only nuclear follistatin immunostaining exhibited a significant reduction (<i>p</i> < 0.05) in specific epithelial layers of cervical tissues from CIN1, CIN2, CIN3, and SCC compared to the control. Decreased immunostaining of cervical βA-activin and follistatin at specific stages of CIN progression suggests that the activin–follistatin system participates in the loss of the differentiation control of pre-neoplastic and neoplastic cervical specimens predominantly positive for HPV.
first_indexed 2024-03-11T03:14:46Z
format Article
id doaj.art-ca337ef502fb431aadb1701145502661
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T03:14:46Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-ca337ef502fb431aadb17011455026612023-11-18T03:37:56ZengMDPI AGViruses1999-49152023-04-01155103110.3390/v15051031Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic LesionsVictor Jesus Huaringa Payano0Lara Verônica de Araújo Lopes1Larissa Rodrigues Peixoto2Keila Alves da Silva3Tania Maria Ortiga-Carvalho4Alexandre Tafuri5Annamaria Ravara Vago6Enrrico Bloise7Laboratório de Patogênese Molecular, Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, BrazilLaboratório de Patogênese Molecular, Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, BrazilLaboratório de Patogênese Molecular, Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, BrazilLaboratório de Patogênese Molecular, Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, BrazilLaboratório de Endocrinologia Translacional, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, BrazilLaboratório de Anatomia Patológica Tafuri, Belo Horizonte 30170-133, MG, BrazilLaboratório de Patogênese Molecular, Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, BrazilLaboratório de Patogênese Molecular, Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-910, MG, BrazilThe activin–follistatin system regulates several cellular processes, including differentiation and tumorigenesis. We hypothesized that the immunostaining of βA-activin and follistatin varies in neoplastic cervical lesions. Cervical paraffin-embedded tissues from 162 patients sorted in control (<i>n</i> = 15), cervical intraepithelial neoplasia (CIN) grade 1 (<i>n</i> = 38), CIN2 (<i>n</i> = 37), CIN3 (<i>n</i> = 39), and squamous cell carcinoma (SCC; <i>n</i> = 33) groups were examined for βA-activin and follistatin immunostaining. Human papillomavirus (HPV) detection and genotyping were performed by PCR and immunohistochemistry. Sixteen samples were inconclusive for HPV detection. In total, 93% of the specimens exhibited HPV positivity, which increased with patient age. The most detected high-risk (HR)-HPV type was HPV16 (41.2%) followed by HPV18 (16%). The immunostaining of cytoplasmatic βA-activin and follistatin was higher than nuclear immunostaining in all cervical epithelium layers of the CIN1, CIN2, CIN3, and SCC groups. A significant decrease (<i>p</i> < 0.05) in the cytoplasmic and nuclear immunostaining of βA-activin was detected in all cervical epithelial layers from the control to the CIN1, CIN2, CIN3, and SCC groups. Only nuclear follistatin immunostaining exhibited a significant reduction (<i>p</i> < 0.05) in specific epithelial layers of cervical tissues from CIN1, CIN2, CIN3, and SCC compared to the control. Decreased immunostaining of cervical βA-activin and follistatin at specific stages of CIN progression suggests that the activin–follistatin system participates in the loss of the differentiation control of pre-neoplastic and neoplastic cervical specimens predominantly positive for HPV.https://www.mdpi.com/1999-4915/15/5/1031βA-activinfollistatinactivininhibincervical intraepithelial neoplasia (CIN)squamous cell carcinoma (SCC)
spellingShingle Victor Jesus Huaringa Payano
Lara Verônica de Araújo Lopes
Larissa Rodrigues Peixoto
Keila Alves da Silva
Tania Maria Ortiga-Carvalho
Alexandre Tafuri
Annamaria Ravara Vago
Enrrico Bloise
Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions
Viruses
βA-activin
follistatin
activin
inhibin
cervical intraepithelial neoplasia (CIN)
squamous cell carcinoma (SCC)
title Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions
title_full Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions
title_fullStr Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions
title_full_unstemmed Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions
title_short Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions
title_sort immunostaining of βa activin and follistatin is decreased in hpv cervical pre neoplastic and neoplastic lesions
topic βA-activin
follistatin
activin
inhibin
cervical intraepithelial neoplasia (CIN)
squamous cell carcinoma (SCC)
url https://www.mdpi.com/1999-4915/15/5/1031
work_keys_str_mv AT victorjesushuaringapayano immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT laraveronicadearaujolopes immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT larissarodriguespeixoto immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT keilaalvesdasilva immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT taniamariaortigacarvalho immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT alexandretafuri immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT annamariaravaravago immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions
AT enrricobloise immunostainingofbaactivinandfollistatinisdecreasedinhpvcervicalpreneoplasticandneoplasticlesions